Oman Journal of Ophthalmology (Jan 2020)

Periocular basal cell carcinoma: 20-years experience at a tertiary eye care center of South India

  • Vathsalya Vijay,
  • Md Shahid Alam,
  • Nirmala Subramanian,
  • Subramanian Krishnakumar,
  • Jyotirmay Biswas,
  • Bipasha Mukherjee

DOI
https://doi.org/10.4103/ojo.OJO_130_2020
Journal volume & issue
Vol. 13, no. 3
pp. 129 – 135

Abstract

Read online

PURPOSE: To study the clinical profile and management outcomes of periocular basal cell carcinoma (BCC). MATERIALS AND METHODS: A retrospective analysis of all histopathologically proven cases of BCC between 1995 and 2015 was done. The demographic data, clinical presentation, histopathological subtype, and management outcomes were analyzed. RESULTS: We had a total of 185 malignant eyelid tumors during the study period, out of which 37 (20%) were BCC. Thirty-two (86.5%) out of 37 cases were primary BCC. The mean age was 63.3 years. Pigmented ulcerative lesion (14, 38%), lower eyelid (19, 51%), and nodular BCC (15, 40%) were the most common presentation, periocular site, and histological subtype, respectively. 28 patients underwent excision under frozen section with an average tumor-free margin of 3.5 mm. Mean follow-up period was 18.78 months. Recurrence rate of 0% and 3.1% was noted in primary and recurrent BCC, respectively. CONCLUSION: Periocular BCC commonly presents as pigmented ulcerative lesion in the lower lid. Excision biopsy under frozen section with an average tumor-free margin of 3.5 mm offers cure in most cases.

Keywords